Antimicrobial potency, prevention ability, and killing efficacy of daptomycin-loaded versus vancomycin-loaded β-tricalcium phosphate/calcium sulfate for methicillin-resistant Staphylococcus aureus biofilms

Growing evidence has shown that the efficacy of systemic administration of daptomycin for the treatment of methicillin-resistant Staphylococcus aureus (MRSA)-related infections is satisfactory. However, the clinical efficacy of the local administration of daptomycin for the management of osteoarticular infections remains unclear. This in vitro study compared the efficacy of daptomycin and vancomycin against MRSA biofilms. The elution kinetics of daptomycin and vancomycin, combined with gentamicin and loaded with either β-tricalcium phosphate/calcium sulfate or calcium sulfate, in the presence of MRSA infection, was assessed. Their efficacy in preventing biofilm formation and killing pre-formed biofilms was assessed using colony-forming unit count and confocal laser scanning microscopy. In addition, the efficacy of daptomycin, vancomycin, and gentamicin in prophylaxis and eradication of MRSA biofilms was also evaluated. Daptomycin + gentamicin and vancomycin + gentamicin displayed similar antimicrobial potency against MRSA, by either β-tricalcium phosphate/calcium sulfate or calcium sulfate. In the prevention assays, both daptomycin + gentamicin and vancomycin + gentamicin showed similar efficacy in preventing bacterial colony formation, with approximately 6 logs lower colony-forming units than those in the control group at both 1 and 3  days. The killing effect on pre-formed biofilms showed significant decreases of approximately 4 logs at 1 and 3  days following treatment with daptomycin + gentamicin and vancomycin + gentamicin. In addition, the confocal laser scanning microscopy results support the colony-forming unit data. Moreover, single use of vancomycin and gentamicin showed similar efficacies in preventing and killing MRSA biofilms, both of which were better than that of gentamicin. Our study demonstrated that vancomycin + gentamicin and daptomycin + gentamicin loaded with β-tricalcium phosphate/calcium sulfate or calcium sulfate showed similar prophylactic and killing effects on MRSA biofilms, implying a potential indication of local administration daptomycin for the treatment of MRSA-associated osteoarticular infections, especially if vancomycin administration presents limitations.

[1]  Sho Tashiro,et al.  Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis , 2022, Pharmaceutics.

[2]  S. Barnini,et al.  Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice , 2022, Antibiotics.

[3]  Siddhartha Sharma,et al.  Drug-loaded biomaterials for orthopedic applications: A review. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[4]  R. G. Richards,et al.  An Enzybiotic Regimen for the Treatment of Methicillin-Resistant Staphylococcus aureus Orthopaedic Device-Related Infection , 2021, Antibiotics.

[5]  D. Lange,et al.  The Combined Use of Gentamicin and Silver Nitrate in Bone Cement for a Synergistic and Extended Antibiotic Action against Gram-Positive and Gram-Negative Bacteria , 2021, Materials.

[6]  R. O’Toole,et al.  Risk factors for treatment failure of fracture-related infections. , 2021, Injury.

[7]  E. Perencevich,et al.  Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  P. Stoodley,et al.  Antibiotic loaded β-tricalcium phosphate/calcium sulfate for antimicrobial potency, prevention and killing efficacy of Pseudomonas aeruginosa and Staphylococcus aureus biofilms , 2021, Scientific reports.

[9]  Yunfei Zhang,et al.  The effect of calcium sulfate/calcium phosphate composite for the treatment of chronic osteomyelitis compared with calcium sulfate. , 2020, Annals of palliative medicine.

[10]  R. G. Richards,et al.  Fracture-related infection: current methods for prevention and treatment , 2020, Expert review of anti-infective therapy.

[11]  Daptomycin , 2020, Reactions Weekly.

[12]  W. Obremskey,et al.  Pathogenesis and management of fracture-related infection. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  J. Geurts,et al.  Antibiotic-Loaded Polymethylmethacrylate Beads and Spacers in Treatment of Orthopedic Infections and the Role of Biofilm Formation , 2019, Front. Microbiol..

[14]  K. Urish,et al.  Large variations in clinical antibiotic activity against Staphylococcus aureus biofilms of periprosthetic joint infection isolates , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[15]  D. Osmon,et al.  Prosthetic Joint Infection Update. , 2018, Infectious disease clinics of North America.

[16]  P. Stoodley,et al.  Antibiotic loaded calcium sulfate bead and pulse lavage eradicates biofilms on metal implant materials in vitro , 2018, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  A. Musset,et al.  Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management , 2018, Journal of tissue engineering.

[18]  Carla Renata Arciola,et al.  Implant infections: adhesion, biofilm formation and immune evasion , 2018, Nature Reviews Microbiology.

[19]  M. Zervos,et al.  Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. , 2016, Clinical therapeutics.

[20]  A. Bettencourt,et al.  Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms , 2015, International journal of nanomedicine.

[21]  L. Azzalis,et al.  The use of vancomycin with its therapeutic and adverse effects: a review. , 2015, European review for medical and pharmacological sciences.

[22]  P. Stoodley,et al.  Antibiotic-Loaded Synthetic Calcium Sulfate Beads for Prevention of Bacterial Colonization and Biofilm Formation in Periprosthetic Infections , 2014, Antimicrobial Agents and Chemotherapy.

[23]  W. Zimmerli,et al.  Clinical presentation and treatment of orthopaedic implant‐associated infection , 2014, Journal of internal medicine.

[24]  P. Finnegan,et al.  Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study. , 2012, Clinical therapeutics.

[25]  R. Reichelt,et al.  Daptomycin: Local Application in Implant-Associated Infection and Complicated Osteomyelitis , 2012, TheScientificWorldJournal.

[26]  K. Baker,et al.  Characterization of daptomycin-loaded antibiotic cement. , 2012, Orthopedics.

[27]  Shengrong Guo,et al.  The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. , 2012, Biomaterials.

[28]  G. Ehrlich,et al.  Orthopaedic biofilm infections , 2011, Current orthopaedic practice.

[29]  G. Corey,et al.  New treatments for methicillin-resistant Staphylococcus aureus , 2009, Current opinion in critical care.

[30]  W. Haggard,et al.  Optimized Elution of Daptomycin from Polymethylmethacrylate Beads , 2008, Antimicrobial Agents and Chemotherapy.

[31]  R. Hancock,et al.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances , 2008, Nature Protocols.

[32]  L. Friedrich,et al.  Clinical experience with daptomycin for the treatment of patients with osteomyelitis. , 2007, The American journal of medicine.

[33]  S. Micek.  Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  M. Kollef.  Limitations of vancomycin in the management of resistant staphylococcal infections. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  T. Turner,et al.  Increased Bone Formation Using Calcium Sulfate-Calcium Phosphate Composite Graft , 2007, Clinical orthopaedics and related research.

[36]  Andreas F Widmer,et al.  Infections associated with orthopedic implants , 2006, Current opinion in infectious diseases.

[37]  D. Jacofsky,et al.  Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber. , 2004, Diagnostic microbiology and infectious disease.

[38]  C. Zalavras,et al.  Local antibiotic therapy in the treatment of open fractures and osteomyelitis. , 2004, Clinical orthopaedics and related research.

[39]  Steven D. Brown,et al.  In vitro bactericidal activity of daptomycin against staphylococci. , 2002, The Journal of antimicrobial chemotherapy.

[40]  M. Hamilton,et al.  How to optimize the drop plate method for enumerating bacteria. , 2001, Journal of microbiological methods.

[41]  R. W. Ross,et al.  Rapid, Modified Kirby-Bauer Susceptibility Test with Single, High-Concentration Antimicrobial Disks , 1973, Antimicrobial Agents and Chemotherapy.